Related Experiment Video
Updated: Feb 15, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease
Thaisa Lucas Sandri1,2, Kárita Cláudia Freitas Lidani1, Fabiana Antunes Andrade1
1Laboratory of Molecular Immunopathology, Federal University of Paraná, Curitiba, Brazil.
Insights
Complement receptor 1 (CR1) levels are lower in Chagas Disease (CD) patients. Specific CR1 variants and haplotypes are linked to T. cruzi infection and chagasic cardiomyopathy risk.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Complement system is crucial in immunity and disease pathogenesis, including Chagas Disease (CD).
- Human complement receptor 1 (CR1) influences pathogen entry and clearance of immune complexes.
- CR1 exon 29 variants are linked to CR1 expression and disease susceptibility.
Purpose of the Study:
- To investigate the association between CR1 plasma levels, CR1 exon 29 variants, and Chagas Disease in a Brazilian cohort.
- To determine the role of CR1 in the immunopathogenesis and clinical presentation of chronic CD.
Main Methods:
- Assessed CR1 plasma levels using ELISA in 232 chronic CD patients and 104 healthy controls.
- Sequenced CR1 exon 29 to identify variants and haplotypes.
- Analyzed statistical associations between CR1 levels, variants, haplotypes, and CD status/clinical outcomes.
Main Results:
- CD patients exhibited significantly lower CR1 plasma levels compared to controls (p < 0.0001).
- CR1 variants rs1704660G, rs17047661G, and rs6691117G were associated with CD and in high linkage disequilibrium.
- The CR1*AGAGTG haplotype correlated with T. cruzi infection (OR 3.99), and CR1*AGGGTG with chagasic cardiomyopathy risk (OR 12.15).
Conclusions:
- This study reveals a significant association between reduced CR1 levels and specific CR1 variants/haplotypes with Chagas Disease.
- Findings provide novel insights into CR1's role in the development and clinical manifestations of chronic Chagas Disease.
Abstract:
Complement is an essential element in both innate and acquired immunity contributing to the immunopathogenesis of many disorders, including Chagas Disease (CD). Human complement receptor 1 (CR1) plays a role in the clearance of complement opsonized molecules and may facilitate the entry of pathogens into host cells. Distinct CR1 exon 29 variants have been found associated with CR1 expression levels, increased susceptibility and pathophysiology of several diseases. In this study, CR1 plasma levels were assessed by ELISA and CR1 variants in exon 29 by sequencing in a Brazilian cohort of 232 chronic CD patients and 104 healthy controls. CR1 levels were significantly decreased in CD patients compared to controls (p < 0.0001). The CR1 rs1704660G, rs17047661G and rs6691117G variants were significantly associated with CD and in high linkage disequilibrium. The CR1*AGAGTG haplotype was associated with T. cruzi infection (p = 0.035, OR 3.99, CI 1.1-14.15) whereas CR1*AGGGTG was related to the risk of chagasic cardiomyopathy (p = 0.028, OR 12.15, CI 1.13-113). This is the first study that provides insights on the role of CR1 in development and clinical presentation of chronic CD.
More Related Videos
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Types of Genetic Transfer Between Organisms
Types of Genetic Transfer Between Organisms
G-protein Coupled Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Types of Receptors: Cell Surface Receptors

